Virtu Financial LLC Aslan Pharmaceuticals LTD Transaction History

Virtu Financial LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 15, 2023	BUY	$0.36 - $24.24 $25,239 - $1.7 Million	70,109 Added 389.56%	88,106 $32,000
Q3 2022 Nov 07, 2022	SELL	$0.42 - $24.68 $51 - $3,010	-122 Reduced 0.67%	17,997 $11,000
Q2 2022 Aug 09, 2022	SELL	$0.36 - $0.9 $2,873 - $7,183	-7,982 Reduced 30.58%	18,119 $9,000
Q1 2022 May 17, 2022	BUY	$0.74 - $1.22 $19,314 - $31,843	26,101 New	26,101 $23,000
Q4 2021 Feb 17, 2022	SELL	$1.11 - $1.86 $58,374 - $97,817	-52,590 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$1.78 - $3.41 $93,610 - $179,331	52,590 New	52,590 $94,000
Q2 2021 Sep 17, 2021	SELL	$2.5 - $3.72 $154,992 - $230,628	-61,997 Closed	0 $0
Q1 2021 May 19, 2021	BUY	$1.86 - $5.25 $89,469 - $252,535	48,102 Added 346.18%	61,997 $208,000
Q4 2020 Feb 24, 2021	BUY	$1.54 - $2.22 $21,398 - $30,846	13,895 New	13,895 $26,000
Q2 2020 Aug 07, 2020	SELL	$0.96 - $2.19 $52,210 - $119,105	-54,386 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$0.37 - $5.2 $20,122 - $282,807	54,386 New	54,386 $110,000

Ticker ASLN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,744,704
Market Cap $41.8M
Description
ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-m...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.